NASDAQ:LABP

TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUSN

Retrieved on: 
Monday, April 22, 2024
CVR, Vertex Pharmaceuticals, Sale, ALPN, AbbVie, Johnson & Johnson, Empire, AstraZeneca, Security (finance)

Under the terms of the agreement, ALPN shareholders are expected to receive $65.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, ALPN shareholders are expected to receive $65.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, SWAV shareholders are expected to receive $335.00 in cash per share they own.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you file class actions and go to Court?

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DOMA, LABP, FUSN, CBNK

Retrieved on: 
Tuesday, April 9, 2024
AbbVie, Empire, AstraZeneca, Integration, Sale, Capital, DOMA, CBNK, CVR, Security (finance)

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Key Points: 
  • NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.
  • Under the terms of the agreement, DOMA shareholders are expected to receive $6.29 in cash per share they own.
  • Capital Bancorp, Inc. (Nasdaq: CBNK ), relating to its proposed merger with Integrated Financial Holdings, Inc.
  • Under the terms of the agreement, CBNK shareholders are estimated to receive $5.36 in cash and 1.115 shares of Capital common stock per share they own.

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN

Retrieved on: 
Monday, April 1, 2024
AbbVie, AstraZeneca, Sale, Fraud, Advertising, Security (finance)

If you are an AdTheorent shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an AdTheorent shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)

Retrieved on: 
Monday, April 1, 2024
AbbVie, AstraZeneca, THL, ABBV, IPO, Thomas H. Lee Partners, Brodsky, AZN, CVR, Security (finance)

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, AdTheorent will be acquired by Cadent, LLC (“Cadent”).
  • The Company’s common stockholders will receive cash consideration of $3.21 per share.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

Kuehn Law Encourages LABP, WRK, KAMN and TGAN Investors to Contact Law Firm

Retrieved on: 
Wednesday, March 27, 2024
Kaman, Transphorm, Renesas Electronics, WestRock, PLLC, Electronics, Smurfit Kappa, Landos, Advertising, AbbVie, Human, Security (finance)

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.

Key Points: 
  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.
  • Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
  • Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at [email protected] or call (833) 672-0814.
  • Kuehn Law covers all case costs and does not charge its investor clients.

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DRQ, FUSN, LABP, FXNC

Retrieved on: 
Wednesday, March 27, 2024
AbbVie, AstraZeneca, Sale, Touchstone, Fraud, Advertising, First National, Security (finance)

If you are a Dril-Quip shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Dril-Quip shareholder, click here to learn more about your rights and options .
  • If you are a Fusion shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)

Retrieved on: 
Monday, March 25, 2024
AbbVie, AstraZeneca, THL, ABBV, Sale, Base, IPO, Thomas H. Lee Partners, Brodsky, AZN, CVR, Security (finance)

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Merger Agreement, Agiliti will be acquired by Thomas H. Lee Partners, L.P. (“THL”).
  • Under the terms of the agreement, Landos Biopharma will be acquired by AbbVie Inc. (“AbbVie”) (NYSE - ABBV).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP

Retrieved on: 
Wednesday, March 27, 2024
Class Action Lawsuit, Professional Services, Legal, KSF, ABBV, Sale, AbbVie

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

Key Points: 
  • Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Landos Biopharma, Inc. (NasdaqCM: LABP) to AbbVie Inc. (NYSE: ABBV).
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders

Retrieved on: 
Monday, March 25, 2024
Legal, Professional Services, AbbVie, Advertising, Sale, Fraud

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Landos Biopharma, Inc. (NASDAQ: LABP) to AbbVie Inc. is fair to Landos shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Landos Biopharma, Inc. (NASDAQ: LABP) to AbbVie Inc. is fair to Landos shareholders.
  • On behalf of Landos shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
  • Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.